Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-24

Clinical Trial Update: Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF) [NA]

View source ↗

Summary

Clinical trial update announcing ongoing recruitment for a study evaluating a dietary fiber supplement in people with Type 2 diabetes mellitus and heart failure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dietary fiber supplement (dietary fiber)

Snippet

Sponsor: University of Michigan | Conditions: Type2diabetes, Heart Failure With Preserved Ejection Fraction | NA | Status: RECRUITING